| Today, Thu, Dec 3, 2009 | | • | Genzyme Resumes Cerezyme Shipment
Zacks.com (Thu 8:24am)
| | • | Above the Fray: 3 PowerRatings Stocks Passing the Test
TradingMarkets.com (Thu 8:22am)
| | Wed, Dec 2, 2009 | | • | [video] Stocks Under $10: 2 Potential Buys
TheStreet.com TV (Wed 8:48am)
| | Tue, Dec 1, 2009 | | • | [$$] Pfizer-Protalix Deal Bolsters Competition For Genzyme
at The Wall Street Journal Online (Tue, Dec 1)
| | • | Business Highlights
AP (Tue, Dec 1)
| | • | Movers roundup: Bed Bath & Beyond
AP (Tue, Dec 1)
| | • | Pfizer inks deal for new drugmaking technology
AP (Tue, Dec 1)
| | • | Pfizer Takes In an Orphan on the Cheap
at Motley Fool (Tue, Dec 1)
| | • | UPDATE - Pfizer acquires rights to Protalix's Gaucher drug
at Reuters (Tue, Dec 1)
| | • | Protalix shares fall following Pfizer deal
AP (Tue, Dec 1)
| | • | [video] Stocks Under $10: 2 Potential Buys
at TheStreet.com (Tue, Dec 1)
| | • | Pfizer, Protalix sign deal for Gaucher drug
at MarketWatch (Tue, Dec 1)
| | • | Pfizer signs development deal with Protalix
AP (Tue, Dec 1)
| | • | Pfizer Chomps On A Carrot
at CNBC (Tue, Dec 1)
| | • | Pfizer Higher on Protalix Deal
at Barrons.com (Tue, Dec 1)
| | • | Protalix-Pfizer Tag Team Against Genzyme: BioBuzz
at TheStreet.com (Tue, Dec 1)
| | • | Genzyme resumes shipping from Allston plant
at MarketWatch (Tue, Dec 1)
| | • | Pfizer Buys Rights To Protalix Drug for As Much as $115 Million
at Fox Business (Tue, Dec 1)
| | • | Protalix Biotherapeutics to Host Analyst and Investor Event
Business Wire (Tue, Dec 1)
| | • | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Tue, Dec 1)
|
Add PLX News to My Yahoo!:
 
| |
|
0.01% Nasdaq 
0.39%
Headlines
